Hee-Ji Eom
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Hee-Ji Eom has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Beom-Ki Jo
College of Pharmacy, Seoul National University, Seoul, Republic of Korea
2 shared publications - Hyuk-Jin Cha
College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, Republic of Korea
2 shared publications - Jumee Kim
College of Pharmacy, Sookmyung Women's University, Seoul, Republic of Korea
2 shared publications - Seung-Woo Cho
Department of Biotechnology, Yonsei University, Seoul, 03722, Republic of Korea
1 shared publication - Seunghee Hong
Department of Biochemistry, College of Life Science and Biotechnology, Yonsei University, Seoul, Republic of Korea; Brain Korea 21 (BK21) FOUR Program, Yonsei Education & Research Center for Biosystems, Yonsei University, Seoul, Republic of Korea
1 shared publication - Woohyun Song1 shared publication
Latest Publications
- Open Access
- 4 June 2026
- Published by Elsevier in Molecules and Cells
- Vol. 49 (8) , 100378
Oxidative stress drives liver failure during in vivo partial reprogramming
- 4 June 2026
- Published by Elsevier in Molecules and Cells
- Vol. 49 (8) , 100378
Open AccessOxidative stress drives liver failure during in vivo partial reprogramming
- Open Access
Enhanced liver regeneration via targeted mRNA delivery for partial in vivo reprogramming
Recent studies suggest that injury-induced dedifferentiation, which leads to the formation of ‘injury-responsive cells’, contributes significantly to tissue repair across various organs, including the liver. Utilizing Yamanaka factors (Oct4, Sox2, Klf4, and c-Myc: OSKM) for in vivo partial reprogramming generates ‘injury-responsive cells’ in the intestine, mirroring those derived from injury-induced dedifferentiation. Thus, the transgene induction of OSKM or viral delivery of Oct4, Sox2, and Klf4 shows promise in facilitating tissue regeneration in the intestine, liver, skeletal muscle, and retina. Herein, we demonstrated that transient OSKM induction produces two distinct liver progenitor-like cell populations. One of these populations resembles liver progenitor-like cells (LPLCs) generated by acute acetaminophen (APAP) injury without triggering immune responses. To explore in vivo reprogramming as a viable strategy for tissue regeneration, we employed lipid nanoparticles (LNP) carrying OSKM mRNA (OSKM mRNA-LNP) to stimulate LPLCs formation. Notably, the production of Sox9+ LPLCs, and OSKM-induced dedifferentiation, was closely correlated with successful tissue regeneration in the liver post APAP injury. Thus, the OSKM mRNA-LNP approach represents a promising therapeutic intervention for the repair of acute liver injuries.
Open AccessEnhanced liver regeneration via targeted mRNA delivery for partial in vivo reprogramming
Recent studies suggest that injury-induced dedifferentiation, which leads to the formation of ‘injury-responsive cells’, contributes significantly to tissue repair across various organs, including the liver. Utilizing Yamanaka factors (Oct4, Sox2, Klf4, and c-Myc: OSKM) for in vivo partial reprogramming generates ‘injury-responsive cells’ in the intestine, mirroring those derived from injury-induced dedifferentiation. Thus, the transgene induction of OSKM or viral delivery of Oct4, Sox2, and Klf4 shows promise in facilitating tissue regeneration in the intestine, liver, skeletal muscle, and retina. Herein, we demonstrated that transient OSKM induction produces two distinct liver progenitor-like cell populations. One of these populations resembles liver progenitor-like cells (LPLCs) generated by acute acetaminophen (APAP) injury without triggering immune responses. To explore in vivo reprogramming as a viable strategy for tissue regeneration, we employed lipid nanoparticles (LNP) carrying OSKM mRNA (OSKM mRNA-LNP) to stimulate LPLCs formation. Notably, the production of Sox9+ LPLCs, and OSKM-induced dedifferentiation, was closely correlated with successful tissue regeneration in the liver post APAP injury. Thus, the OSKM mRNA-LNP approach represents a promising therapeutic intervention for the repair of acute liver injuries.